Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.
To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
----------------------------------------------
** BREAST CANCER News **
Latinas, Blacks More Dissatisfied Than Whites With Breast Cancer Decisions, Study Finds
http://www.medicalnewstoday.com/articles/128504.php
<BR>Latina and African-American breast cancer patients -- especially Latinas who prefer to speak Spanish -- are more likely than white patients to be dissatisfied with the decision-making process of how to proceed with a breast cancer diagnosis, according to a <A href="http://www.
----------------------------------------------
** CANCER / ONCOLOGY News **
CIGNA To Promote The Leukemia & Lymphoma Society's Co-Pay Assistance Program, USA
http://www.medicalnewstoday.com/articles/128614.php
CIGNA Pharmacy Management (CIGNA) and the Leukemia & Lymphoma Society (LLS) are joining forces to promote LLS's efforts to help blood cancer patients cover the costs of prescription co-pays and health insurance premiums.
Study Showed Tarceva Improved Progression-Free Survival As A First-Line Maintenance Therapy For Advanced Non-Small Cell Lung Cancer
http://www.medicalnewstoday.com/articles/128609.php
Genentech, Inc. (NYSE:DNA) and OSI Pharmaceuticals, Inc. (Nasdaq:OSIP) today announced that a global Phase III study (SATURN) met its primary endpoint and showed Tarceva® (erlotinib) significantly extended the time patients with advanced non-small cell lung cancer (NSCLC) lived without their cancer getting worse when given immediately following initial treatment with platinum-based chemotherapy, compared to placebo.
Cancer Services Open Day 2008, North Bristol NHS Trust, England - November 20th, 2008
http://www.medicalnewstoday.com/articles/128604.php
North Bristol NHS Trust's annual Cancer Services Open Day takes place on Thursday, November 20 at the Centre for Medical Education at Southmead Hospital. The free event, which runs from 10am-4pm, is open to everyone with an interest in cancer - this includes patients, carers and medical professionals.
Researchers Find Predictive Tests And Early Treatment Delay Progression Of Blood Cell Cancer
http://www.medicalnewstoday.com/articles/128567.php
Mayo Clinic researchers say they have moved closer to their goal of providing personalized care for a common blood cell cancer. They have found that the use of predictive biomarkers along with two targeted treatments significantly delays the need for conventional chemotherapy in patients with early-stage, but high-risk, chronic lymphoid leukemia (CLL).
Achilles' Heel In Pancreatic Cancer Discovered By UC Davis Researchers
http://www.medicalnewstoday.com/articles/128555.php
UC Davis Cancer Center researchers have discovered a metabolic deficiency in pancreatic cancer cells that can be used to slow the progress of the deadliest of all cancers.Published in the October issue of the <i>International Journal of Cancer</i>, study results indicate that pancreatic cancer cells cannot produce the amino acid arginine, which plays an essential role in cell division, immune function and hormone regulation.
Pediatric Cancer : Alteration Of A Gene Causes Neuroblastoma
http://www.medicalnewstoday.com/articles/128489.php
Olivier Delattre's team (Inserm Unit 830 "Genetics and Biology of Cancer") of the Institut Curie reveal in an article in the 16 October issue of Nature that alteration of the ALK gene is closely associated with the most frequent solid extracerebral tumor in childre neuroblastoma.
Dendreon Presents Integrated Analysis Of Clinical Data From NEUVENGE Trials At Chemotherapy Foundation Symposium
http://www.medicalnewstoday.com/articles/128484.php
Dendreon Corporation (Nasdaq: DNDN) will present a summary of Phase 1 clinical data of NEUVENGE(TM) (lapuleucel-T), an investigational active cellular immunotherapy, at the Chemotherapy Foundation Symposium in New York City.
Poniard Pharmaceuticals Announces Final Top-Line Results From Phase 1 Trial Demonstrating Positive Bioavailability With Oral Picoplatin
http://www.medicalnewstoday.com/articles/128482.php
Poniard Pharmaceuticals, Inc. (Nasdaq: PARD), a biopharmaceutical company focused on oncology, announced top-line results from its Phase 1 clinical trial of an oral formulation of picoplatin in patients with solid tumors showing that picoplatin achieves linear and dose-dependent plasma exposure when given by the oral route.
----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **
Scarce Economic Resources Lead Irish Government To Abandon HPV Vaccination Plan
http://www.medicalnewstoday.com/articles/128502.php
<BR>The Irish government on Tuesday announced that "very scarce" health resources have led it to abandon a plan to vaccinate all 12-year-old girls in the republic against human papillomavirus, some strains of which can lead to cervical cancer, the <A href="http://www.
----------------------------------------------
** COLORECTAL CANCER News **
Studies Examine Whether Information About Colon Cancer Discourages Blacks From Screening; Job Stress Among Filipino Immigrants
http://www.medicalnewstoday.com/articles/128549.php
"<a href="http://cebp.aacrjournals.org/cgi/content/abstract/17/11/2946" target="_new"><u>Unintended Effects of Emphasizing Disparities in Cancer Communication to African-Americans</u></a>," <cite>Cancer Epidemiology, Biomarkers & Prevention</cite>: For the study, researcher Robert Nicholson, an assistant professor in the Department of Neurology and Psychiatry at the St.
----------------------------------------------
** LUNG CANCER News **
Study Showed Tarceva Improved Progression-Free Survival As A First-Line Maintenance Therapy For Advanced Non-Small Cell Lung Cancer
http://www.medicalnewstoday.com/articles/128609.php
Genentech, Inc. (NYSE:DNA) and OSI Pharmaceuticals, Inc. (Nasdaq:OSIP) today announced that a global Phase III study (SATURN) met its primary endpoint and showed Tarceva® (erlotinib) significantly extended the time patients with advanced non-small cell lung cancer (NSCLC) lived without their cancer getting worse when given immediately following initial treatment with platinum-based chemotherapy, compared to placebo.
----------------------------------------------
** LYMPHOMA / LEUKEMIA News **
CIGNA To Promote The Leukemia & Lymphoma Society's Co-Pay Assistance Program, USA
http://www.medicalnewstoday.com/articles/128614.php
CIGNA Pharmacy Management (CIGNA) and the Leukemia & Lymphoma Society (LLS) are joining forces to promote LLS's efforts to help blood cancer patients cover the costs of prescription co-pays and health insurance premiums.
All Patients Should Have Access To The Novel Therapies For Myeloma, Says International Myeloma Foundation
http://www.medicalnewstoday.com/articles/128612.php
The International Myeloma Foundation (IMF)-supporting research and providing education, advocacy and support for myeloma patients, families, researchers and physicians-today called for all patients to have access to the newest pharmaceuticals making life-changing advances in the treatment of myeloma.
Researchers Find Predictive Tests And Early Treatment Delay Progression Of Blood Cell Cancer
http://www.medicalnewstoday.com/articles/128567.php
Mayo Clinic researchers say they have moved closer to their goal of providing personalized care for a common blood cell cancer. They have found that the use of predictive biomarkers along with two targeted treatments significantly delays the need for conventional chemotherapy in patients with early-stage, but high-risk, chronic lymphoid leukemia (CLL).
----------------------------------------------
** PROSTATE / PROSTATE CANCER News **
Herb Studied For Enlarged Prostate - Saw Palmetto Therapeutic For Urinary Symptoms?
http://www.medicalnewstoday.com/articles/128534.php
Physician-scientists are studying an herbal supplement that might aid in reducing the symptoms of an enlarged prostate in men. Recent figures show that benign prostatic hyperplasia (BPH) occurs in an estimated 50 percent of men over the age of 50 and in 75 percent of men 80 and older.
Krongrad Institute Launches Ground Breaking Trial Of Minimally Invasive Surgery For Chronic Prostatitis
http://www.medicalnewstoday.com/articles/128522.php
Chronic prostatitis is a prostatic disease of relatively young men. It is associated with a cluster of potentially debilitating symptoms, including pain and bleeding upon urination and/or ejaculation, fever, malaise, and weakness.
-------------------------------------------------------------
You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
No comments:
Post a Comment